| Biomarker ID | 822 |
| PMID | 22142399 |
| Year | 2011 |
| Biomarker | TDRD1 |
| Biomarker Basis | Expression Based |
| Biomolecule | mRNA |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Upregulated in Prostate cancer |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways Include:-Gene Expression,Mitotic Prophase,PIWI-interacting RNA (piRNA) biogenesis |
| Experiment | Benign Vs Tumor |
| Type of Biomarker | Diagnostic |
| Cohort | 47 prostate tumor tissue samples and in 48 normal prostate tissue samples taken from the non-suspect area of clinical low-risk tumors. GEO Accession: GSE29079. Validation cohort 29 benign and 72 fusion-negative and 48 fusion-positive tumor samples. |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.05 |
| Method Used | RT-PCR |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on Independent Patient Cohort |
| Technical Name | TDRD1 |